Mila M. Prill

机构：Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases · ORCID：0000-0002-1175-417X

发表论文 81 篇 · 总被引 8039 次 · h-index 33

代表论文

• Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 (2020 · MMWR Morbidity and Mortality Weekly Report · 被引 2470)
• Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic — United States, 2020–2021 (2021 · MMWR Morbidity and Mortality Weekly Report · 被引 638)
• Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 (2023 · MMWR Morbidity and Mortality Weekly Report · 被引 368)
• Seasonality of Respiratory Syncytial Virus — United States, 2017–2023 (2023 · MMWR Morbidity and Mortality Weekly Report · 被引 328)
• Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 (2023 · MMWR Morbidity and Mortality Weekly Report · 被引 310)
• Respiratory Syncytial Virus–Associated Hospitalizations Among Young Children: 2015–2016 (2020 · PEDIATRICS · 被引 280)